TransMedics (TMDX) Capital Expenditures (2018 - 2026)

TransMedics has reported Capital Expenditures for 9 years, with the latest figure at $7.1 million in Q2 2026.

• On a quarterly basis, Capital Expenditures fell 21.85% year-over-year to $7.1 million in Q2 2026; TTM through Jun 2026 was $66.9 million, a 31.69% decrease from a year earlier, with the FY2025 full-year figure at $59.3 million, down 54.33% from the prior year.
• Capital Expenditures was $7.1 million for Q2 2026 at TransMedics, down from $36.7 million in the prior quarter.
• The five-year high for Capital Expenditures was $107.7 million in Q3 2023, with the low at $927000.0 in Q1 2023.
• Average Capital Expenditures over 5 years is $22.0 million, with a median of $11.3 million recorded in 2024.
• The sharpest annual moves came in 2022 and 2025: Capital Expenditures surged 9665.0% in 2022, then plunged 84.18% in 2025.
• Over 5 years, Capital Expenditures stood at $2.8 million in 2022, then soared by 1412.95% to $41.8 million in 2023, then tumbled by 67.46% to $13.6 million in 2024, then climbed by 14.02% to $15.5 million in 2025, then sank by 54.29% to $7.1 million in 2026.
• The last three Capital Expenditures figures came in at $7.1 million (Q2 2026), $36.7 million (Q1 2026), and $15.5 million (Q4 2025), per Business Quant data.